Best treatments for atherosclerosis
3 products may treat atherosclerosis. The current highest-rated option is repatha. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 3 drugs we list for atherosclerosis, none are yet flagged as generics in our price data. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for atherosclerosis — so confirm the right choice with your prescriber.
Top-rated picks for atherosclerosis: 1. Repatha · 2. Praluent · 3. Nexletol
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | — | No data | — | View → | |
| 2 | 70/100 | Prescription | Injectable | — | No data | — | View → | |
| 3 | Not yet rated | Prescription | Tablet | — | No data | — | View → |
Full ranking · 3 treatments
repatha
PrescriptionFDA-sourced
Repatha (Evolocumab) is a medication used to treat Hypercholesterolemia, Atherosclerosis.
Price varies
praluent
PrescriptionFDA-sourced
Praluent (Alirocumab) is a medication used to treat Hypercholesterolemia, Atherosclerosis.
Price varies
nexletol
PrescriptionFDA-sourced
Nexletol (Bempedoic Acid) is a medication used to treat Hyperlipoproteinemia Type II, Atherosclerosis.
Price varies
Frequently asked
- What treats atherosclerosis?
- Our catalog lists 3 products that may treat atherosclerosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is repatha.
- What is the best-rated treatment for atherosclerosis?
- By our independent recall-safety rating — not an efficacy measure — repatha ranks highest among the products we list for atherosclerosis. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.